Inventor
DAVID CHERNOFF
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Nprimary
A61NElectrotherapy27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
A61BDiagnosis9%
A61KPreparations for medical, dental or toiletry purposes9%
C07KPeptides9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
PatentTitleYear
12,582,819Treatment of inflammatory disorders202612,392,785Adjusted multi-biomarker disease activity score for inflammatory disease assessment202512,343,535Vagus nerve stimulation to treat neurodegenerative disorders202512,172,017Vagus nerve stimulation to treat neurodegenerative disorders2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2026Patents assigned to SETPOINT MEDICAL CORP (3)· patent assignee history
2024–2026Based in US· patent location history
2025Patents assigned to LABORATORY CORP AMERICA HOLDINGS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SETPOINT MEDICAL CORP | 3 | 2024–2026 |
| LABORATORY CORP AMERICA HOLDINGS | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2024–2026 |